Bringing IDH into the Fold

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart Moshi Song, Gerald W. Dorn Cell Metabolism Volume 21, Issue.
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
WHAMM Is an Arp2/3 Complex Activator That Binds Microtubules and Functions in ER to Golgi Transport Kenneth G. Campellone, Neil J. Webb, Elizabeth A. Znameroski,
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
T-ALL: Home Is where the CXCL12 Is
A Novel Link between Inflammation and Cancer
Of Brains and Blood: Developmental Origins of Glioma Diversity?
Kristin G. Anderson, Ingunn M. Stromnes, Philip D. Greenberg 
Settling a Nervous Stomach: The Neural Regulation of Enteric Cancer
“Atypical” Regulation of Hedgehog-Dependent Cancers
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Intravascular Survival and Extravasation of Tumor Cells
Kenneth L. Scott, Scott Powers  Cancer Cell 
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
Fall of the Optical Wall: Freedom from the Tyranny of the Microscope Improves Glioma Risk Stratification  Vijay Ramaswamy, Michael D. Taylor  Cancer Cell 
Genetic Classification of Gliomas: Refining Histopathology
Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel  Cell Stem Cell 
Elodie Pronier, Ross L. Levine  Cancer Cell 
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
No Need for Constant Help: Human IgG2 Antibodies Have an Autonomous Agonistic Activity for Immunotherapy of Cancer  Anja Lux, Falk Nimmerjahn  Cancer.
Tumor Evolution: A Problem of Histocompatibility
MSCs, Macrophages, and Cancer: A Dangerous Ménage-à-Trois
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
DAISY: Picking Synthetic Lethals from Cancer Genomes
Tipping the Balancing ACT
Volume 26, Issue 1, Pages 1-2 (July 2014)
Applications of Immunogenomics to Cancer
Regulating Cancer Stem Cells the miR Way
A Radical Role for p38 MAPK in Tumor Initiation
IDH1, Histone Methylation, and So Forth
Doria Filipponi, Julius Muller, Alexander Emelyanov, Dmitry V. Bulavin 
Pontine Infantile Glioma Simplified
Cancer Cell of Origin: Spotlight on Luminal Progenitors
New Views into the Genetic Landscape of Metastatic Breast Cancer
Volume 131, Issue 1, Pages (October 2007)
CHD7 in Charge of Neurogenesis
Of Brains and Blood: Developmental Origins of Glioma Diversity?
MicroRNAs and Parallel Stem Cell Lives
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Correlation Does Not Imply Causation: Histone Methyltransferases, but Not Histone Methylation, SET the Stage for Enhancer Activation  Tim Pollex, Eileen.
Common TLR5 Mutations Control Cancer Progression
Characterizing the Killer Colorectal Carcinomas
The Bony Side of Endothelial Cells in Prostate Cancer
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Kenneth L. Scott, Scott Powers  Cancer Cell 
BMPing Off Glioma Stem Cells
NO Signals from the Cancer Stem Cell Niche
The Plasticity of Aging: Insights from Long-Lived Mutants
Selfish Stem Cells Compete with Each Other
It’s ALL in the Family: IKZF1 and Hereditary Leukemia
Mutant BRAF Melanomas—Dependence and Resistance
To Infinium, and Beyond! Cancer Cell
Chaos Controlled: Discovery of a Powerful Amyloid Inhibitor
c-Raf in KRas Mutant Cancers: A Moving Target
Volume 17, Issue 2, Pages (February 2010)
Volume 12, Issue 6, Pages (December 2007)
Notching Up MYC Gives a LIC
Christopher G. Abraham, Joaquín M. Espinosa  Cancer Cell 
The Role of TET2 in Hematologic Neoplasms
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

Bringing IDH into the Fold Gelareh Zadeh, Kenneth Aldape  Cancer Cell  Volume 29, Issue 2, Pages 139-140 (February 2016) DOI: 10.1016/j.ccell.2016.01.010 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Schematic Showing the Relationship of IDH Mutation Status to Insulator Function in Glioma In IDH-wild-type glioma (top panel), the FIP1L1 enhancer activates FIP1L1 expression. PDGFRA expression is insulated from this effect (via CTCF insulator binding). In contrast, IDH mutant tumors (lower panel) show aberrant methylation, reducing the binding of the insulator and resulting in elevated expression of PDGFRA to promote gliomagenesis. Cancer Cell 2016 29, 139-140DOI: (10.1016/j.ccell.2016.01.010) Copyright © 2016 Elsevier Inc. Terms and Conditions